NHAS
AKBA icon

Novo Holdings A/S’s Akebia Therapeutics AKBA Stock Holding History

Novo Holdings A/S’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,987,506
Closed -$4.99M – 46
2020
Q3 		$4.99M Hold
1,987,506
– – 0.25% 40
2020
Q2 		$27M Sell
1,987,506
-1,405,533
-41% -$14.5M 1.74% 12
2020
Q1 		$25.7M Buy
3,393,039
+293,039
+9% +$2.28M 1.72% 9
2019
Q4 		$19.6M Hold
3,100,000
– – 1.26% 11
2019
Q3 		$12.2M Hold
3,100,000
– – 2.08% 13
2019
Q2 		$15M Hold
3,100,000
– – 2.1% 12
2019
Q1 		$25.4M Hold
3,100,000
– – 3.76% 6
2018
Q4 		$17.1M Hold
3,100,000
– – 2.41% 8
2018
Q3 		$27.4M Hold
3,100,000
– – 2.17% 5
2018
Q2 		$30.9M Hold
3,100,000
– – 3.11% 5
2018
Q1 		$29.5M Buy
3,100,000
+875,000
+39% +$12.2M 3.7% 6
2017
Q4 		$33.1M Buy
2,225,000
+337,465
+18% +$5.6M 4.64% 5
2017
Q3 		$37.1M Buy
1,887,535
+73,246
+4% +$1.13M 4.83% 6
2017
Q2 		$26.1M Buy
1,814,289
+542,042
+43% +$6.87M 3.12% 9
2017
Q1 		$11.7M Buy
+1,272,247
New +$12.4M 1.25% 16
2015
Q4 		– Sell
-1,516,387
Closed -$14.6M – 16
2015
Q3 		$14.6M Hold
1,516,387
– – 1.51% 11
2015
Q2 		$15.6M Hold
1,516,387
– – 1.12% 14
2015
Q1 		$16.8M Hold
1,516,387
– – 1.43% 10
2014
Q4 		$17.7M Hold
1,516,387
– – 1.43% 11
2014
Q3 		$33.6M Hold
1,516,387
– – 3.27% 7
2014
Q2 		$42.1M Buy
+1,516,387
New +$36.5M 4.17% 6

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Novo Holdings A/S's AKBA Position: Q4 2020 in Review

Novo Holdings A/S sold out of Akebia Therapeutics (AKBA) in Q4 2020, closing a stake of 1,987,506 shares — an estimated $4.99M sold.

Novo Holdings A/S first reported a position in AKBA in Q2 2014 and held it in 21 quarters. The position peaked at $42.1M in Q2 2014. 143 funds tracked by Wall St. Rank hold AKBA as of Q4 2020.

  • Novo Holdings A/S reported no remaining Akebia Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Novo Holdings A/S sold 1,987,506 Akebia Therapeutics shares in Q4 2020, an estimated $4.99M.
  • Novo Holdings A/S first reported a position in Akebia Therapeutics in Q2 2014 and held it in 21 quarters.
  • Novo Holdings A/S's Akebia Therapeutics position peaked at $42.1M in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2020.

Based on Novo Holdings A/S's 13F filing for Q4 2020, filed 16 Feb 2021.